Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.71
+0.41 (5.62%)
At close: Aug 22, 2025, 4:00 PM
7.59
-0.12 (-1.56%)
After-hours: Aug 22, 2025, 7:52 PM EDT
Kazia Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Kazia Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $14, which forecasts a 81.58% increase in the stock price over the next year. The lowest target is $13 and the highest is $15.
Price Target: $14 (+81.58%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 10, 2025.
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $13 | Strong Buy | Maintains | $2 → $13 | +68.61% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +94.55% | Jun 11, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +94.55% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +1,197.02% | Jul 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $100 | Hold → Strong Buy | Upgrades | $100 | +1,197.02% | Apr 11, 2023 |
Financial Forecast
Revenue This Year
34.17K
from 2.48M
Decreased by -98.62%
Revenue Next Year
51.00K
from 34.17K
Increased by 49.25%
EPS This Year
-26.52
from -50.78
EPS Next Year
-12.95
from -26.52
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 70,350 | 105,000 | 64,050 | |||
| Avg | 34,170 | 51,000 | 31,110 | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -97.2% | 207.3% | 25.6% | |||
| Avg | -98.6% | 49.3% | -39.0% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -27.30 | -13.34 | -10.34 | |||
| Avg | -26.52 | -12.95 | -10.05 | |||
| Low | -25.48 | -12.45 | -9.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.